Zhongzhi Pharmaceutical Holdings Limited (SEHK: 3737)
Health Care · Pharmaceuticals · CN
HK$0.68
+4.62% today · -17.1% 1Y
Zhongzhi Pharmaceutical Holdings Limited (SEHK: 3737) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $74.90M and employs 2,284 people.
Over the last twelve months the share price has lost 17.1%, trading between 0.50 and 0.98.
Tweenvest scores Zhongzhi Pharmaceutical Holdings Limited across four factors: quality 74/100, value 39/100, growth 35/100. Its strongest factor is quality.
3737 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $74.90M
- Revenue (TTM)
- $248.41M
- P/E
- 30.55
- EPS
- 0.02
- Dividend yield
- —
- Beta (5Y)
- 0.42
- 52-week high
- HK$0.98
- 52-week low
- HK$0.50
- Avg volume (3M)
- —
- Shares outstanding
- 863.60M
- Employees
- 2,284
- Next earnings
- —
About Zhongzhi Pharmaceutical Holdings Limited
Zhongzhi Pharmaceutical Holdings Limited, an investment holding firm based in the People's Republic of China, focuses on the entire lifecycle of pharmaceutical products, from research and development to manufacturing and distribution. Its operations are structured across three main divisions: pharmaceutical production, management of its physical retail pharmacy chain, and its online pharmacy platform. The company offers Chinese patent medicines and traditional Chinese decoction pieces, marketed under prominent brands such as Zeus, Liumian, and Caojinghua. In addition to its core pharmaceutical activities, Zhongzhi also produces and sells food products and traditional Chinese herbs, manages properties, and offers detection and testing services. By the end of 2021, the company managed a network of 398 self-owned retail pharmacies. Of these, 361 were approved for medical insurance payments and are situated in Zhongshan, Guangdong Province, operating under the Zeus brand. Established in 1993, the company's headquarters are also located in Zhongshan, PRC. Crystal Talent Investment Group Limited holds a controlling stake in Zhongzhi Pharmaceutical Holdings Limited.
- ISIN
- KYG989611085
- Founded
- 1993
- Listed since
- Jul 13, 2015
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.